Amazing experience cooperating with VectorBuilder! As one of the most popular technologies, mRNA vaccine technology has been used extensively to develop therapeutics and vaccines targeting various infectious and non-infectious diseases. Recently, Daniel Meng’s R&D team at VectorBuilder rapidly established the IVT mRNA CRO platform, and we closely collaborated on developing mRNA-based HIV and influenza vaccines. I am so impressed by their scientific vision as well as their problem solving capabilities. Once again, VectorBuilder is trustworthy.
Dr. Caijun Sun
Sun Yat-sen University, Guangzhou, China